Overview
Arizona Pharmacy Association’s (AzPAs) Psychiatric Certificate Program (PCP) began in 2013 and is a practice-based activity designed for pharmacists in all practice settings. The intent of the home study and live virtual seminar is to provide additional training in the area of psychiatric pharmacy practice to enhance pharmacists’ clinical knowledge that can be applied directly to the patients they serve.
How it Works
HOME STUDY:
- Self-Assessment: each participant must complete a self-assessment to gauge their comfort level of the material before completing the program. This will also be assessed again at the conclusion of the live seminar.
- Learning Modules: Seven modules (book chapters) are required reading to ensure all participants have a basic understanding of psychiatric disorders.
- Module 1: Schizophrenia
- Module 2: Major Depressive Disorder
- Module 3: Bipolar Disorder
- Module 4: Anxiety and Trauma-Related Disorders
- Module 5: Sleep Disorders
- Module 6: Attention-Deficit/Hyperactivity Disorder
- Module 7: Substance Related Disorders
- Recorded Program: Prior to the live seminar, each participant should listen to a recorded webinar to become familiar with topics that were not covered in the home study learning modules.
- "Preventative Approaches for Healthcare"-Martha Fankhauser, MS Pharm, FASHP, FAzPA, BCPP
- Part I: Neuropharmacology, Polypharmacy, and Deprescribing
- Part II: Nutrition, Exercise, Sleep, Hormones and Substances.
- "Preventative Approaches for Healthcare"-Martha Fankhauser, MS Pharm, FASHP, FAzPA, BCPP
- Patient Encounters: There are patient-based exercises in each module that should be completed as part of the content structure for this activity. AzPA faculty will discuss the patient encounters and the recommended tables or figures during the live seminar.
- Examination: Each participant must complete an online examination and score a 70% or better to receive a passing grade. There are 10 exam questions from each module with a multiple-choice format. Do not start the test unless you plan to finish in one sitting.
LIVE SEMINAR:
- The live virtual seminar includes six didactic presentations as well as interactive training to practice comprehensive medication therapy management skills in the area of psychiatric disorders.
- Examination: After the live seminar, each participant must complete an online examination and score a 70% or better to receive a passing grade. There are 65 case-based exam questions taken from each module with a multiple-choice format.
Continuing Education
Activity Type: Practice Based
Target Audience: Pharmacists in all practice settings
Successful completion of the entire program will result in 26.5 contact hours of CPE credit (2.65 CEUs). ACPE UAN: 0100-22-004-CP
- 18.5 hours (1.85 CEU) is awarded for completion of the home study learning portion | ACPE UAN: 0100-0000-22-163-H01-P
- Initial Date of Release: January 1, 2023 | Expiration Date: January 1, 2026
- 8 hours (0.8 CEU) is awarded for completion of the live training seminar. | ACPE UAN: 0100-0000-22-164-L01-P
- Initial Date of Release: January 1, 2023 | Expiration Date: January 1, 2026
Credits will be uploaded within 30 days from the live session date. It is the participants responsibility to ensure your credits are uploaded within 60 days from the live session date. After this time you will no longer be able to claim your CPE credit.
A Certificate of Achievement is awarded to participants who successfully complete all activity requirements:
- Successful completion of the self-study component involves completing the self-assessments, the self-study activity, and passing the online exam with a score of 70% or above.
- Successful completion of the live seminar component involves attending the full live seminar and passing the final exam with a score of 70% or above. In addition, participants must complete a final program evaluation.
Accreditation
The AzPA Psychiatric Certificate Training Program was developed by AzPA for pharmacists. The Arizona Pharmacy Association are accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.
Course Information
- Provide training to enhance a practitioner’s ability to effectively assess, monitor, and manage the pharmacotherapy of patients with psychiatric disorders.
- Deliver comprehensive medication therapy management to prevent, treat, and monitor psychiatric disorders using patient-centered care.
- Promote appropriate and optimal medication use and adherence that minimizes drug interactions, polypharmacy, and adverse effects.
- Encourage healthy lifestyles and nonpharmacologic treatment approaches for optimizing a person’s mental and physical health.
- Discuss the epidemiology, etiology, and risk factors for the development of each selected psychiatric disorder.
- Describe the typical clinical presentation and diagnostic criteria of each selected psychiatric disorder.
- Evaluate selected patient cases and determine whether a given patient exhibits signs and/or symptoms of each selected psychiatric disorders.
- Describe the clinical course of each selected psychiatric disorder.
- Compare and contrast the efficacy, safety, tolerability, monitoring parameters, and clinically significant drug interactions of pharmacologic treatment modalities commonly prescribed in the treatment of each selected psychiatric disorder.
- Recommend appropriate initial pharmacotherapy and therapeutic alterations/adjustments according to clinical practice guidelines.
- Recognize and effectively manage common drug interactions associated with the treatment of each selected psychiatric disorders.
- Formulate appropriate counseling information to be given to patients, or caregivers of patients, for prescribed pharmacotherapy in the treatment of each selected psychiatric disorder.
- Recommend strategies to minimize commonly experienced adverse drug events from prescribed medications.
- Integrate nonpharmacologic therapies that improve the patient’s health and maximize social, work, and educational outcomes.
Morning | Part 1
- Attention Deficit/Hyperactivity Disorders
- Schizophrenia
- Bipolar Disorder
Afternoon | Part 2
- Major Depressive Disorder
- Anxiety Disorders
- Sleep Disorders
- Martha Fankhauser, MS Pharm, FASHP, FAzPA, BCPP, Neuropsychiatric Pharmacist
- Nina Vadiei, PharmD, BCPP, Clinical Pharmacy Specialist in Psychiatry
Accreditation: The AzPA Psychiatric Certificate Training Program was developed by AzPA for pharmacists. The Arizona Pharmacy Association are accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.